Stelara (Ustekinumab) Versus Etanercept for Psoriasis

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF DRUGS IN DERMATOLOGY | 2010年 / 9卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：572 / 572
页数：1
相关论文
共 50 条
  • [21] Weight and demographic characteristics of psoriasis patients treated with adalimumab, etanercept, or ustekinumab
    Meyer, Roxanne
    Yeaw, Jason
    Zhang, Mingliang
    Hines, Dionne
    Wade, Ron
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB257 - AB257
  • [22] FDA Approves Stelara to Treat Psoriasis
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (12) : 1150 - 1150
  • [23] Extension of Approval for Stelara® (Ustekinumab) for the Treatment of Ulcerative colitis
    VISCERAL MEDICINE, 2019, 35 (06) : 399 - 399
  • [24] Cost effectiveness - Analysis of Therapy with Ustekinumab versus Etanercept in Patients with moderate to severe Plaque Psoriasis Based on the ACCEPT Study
    Augustin, M.
    Feldman, S.
    Wolbring, F.
    Szapary, P.
    Schenkel, B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 191 - 191
  • [25] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Villacorta, Reginald
    Hay, Joel W.
    Messali, Andrew
    PHARMACOECONOMICS, 2013, 31 (09) : 823 - 839
  • [26] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Reginald Villacorta
    Joel W. Hay
    Andrew Messali
    PharmacoEconomics, 2013, 31 : 823 - 839
  • [27] Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis
    Martin, Silas
    Feldman, Steven R.
    Augustin, Matthias
    Szapary, Philippe
    Schenkel, Brad
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2011, 22 (03) : 138 - 143
  • [28] Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or Ustekinumab
    Carter, Chureen
    Wilson, Kathleen L.
    Smith, David
    Lee, Seina
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (05) : 191 - 198
  • [29] Systemic profile of psoriasis: the effects of ustekinumab and etanercept following 12 weeks of treatment
    Brodmerkel, C.
    Kikuchi, T.
    Fidelus-Gort, R.
    Khatcherian, A.
    Novitskaya, I
    Baribaud, F.
    Krueger, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S26 - S26
  • [30] Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept
    Brodmerkel, Carrie
    Li, Katherine
    Garcet, Sandra
    Hayden, Karen
    Chiricozzi, Andrea
    Novitskaya, Inna
    Fuentes-Duculan, Judilyn
    Suarez-Farinas, Mayte
    Campbell, Kim
    Krueger, James G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (05) : 1965 - 1969
12345